BUD — Budget/Appropriations
H.R.7148 - Consolidated Appropriations Act, 2026
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
12e1fca5-793d-4526-9450-80bea73b8142- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-20 21:07:27
- Income (reported)
- —
- Expenses (reported)
- $280,000
- Expenses method
- B
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Charitable funder of diabetes research
- Contact
- LAURA WHITTON
- Phone
- +1 202-465-4103
- Address
- zip:20005, city:WASHINGTON, state:DC, street:1400 K STREET, NW, SUITE 1212
Client
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- State
- DC
- Country
- US
- Government-entity client
- false
- Effective date
- 2009-10-07
Issues lobbied + lobbyists
HCR — Health Issues
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 S. 3064 - the Relief of Chronic Disease Pain Act of 2026 S. 4189 - the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026 H.R. 5467 - the Patient Access to Autoimmune Treatments Act S. 3105 / H.R. 8018 - the Increase Support for Life-saving Endocrine Transplantation Act Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to NIH research Issues pertaining to NIH/FDA funding Issues pertaining to screening and early detection
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE